SEC-sourced researchBeta
VTVT
vTv Therapeutics Inc.
Company comparison ↗
Data passport
- CIK
- 0001641489
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Oct 6, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 0.0000 | Mar 10, 2026 |
| December 2024 | 1,017,000.0000 | Mar 10, 2026 |
| December 2025 | 0.0000 | Mar 10, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 0.0000 | -26,974,000.0000 | -25,255,000.0000 | 89,899,000.0000 | 25,462,000.0000 | Mar 10, 2026 |
| December 2024 | 1,017,000.0000 | -18,462,000.0000 | -25,307,000.0000 | 38,266,000.0000 | 23,965,000.0000 | Mar 10, 2026 |
| December 2023 | 0.0000 | -20,250,000.0000 | -19,081,000.0000 | — | — | Mar 10, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $0 | December 2025 | Mar 10, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.02M | December 2024 | Mar 10, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$26.97M | December 2025 | Mar 10, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$25.26M | December 2025 | Mar 10, 2026 | 10-K |
| Total assetsAssets | $89.9M | December 2025 | Mar 10, 2026 | 10-K |
| Total liabilitiesLiabilities | $25.46M | December 2025 | Mar 10, 2026 | 10-K |